# Link Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/link-therapeutics

- Industry: Biotechnology
- Headquarters: Kyoto-shi, Japan
- Website: www.link-therapeutics.com/
- Total disclosed funding: $7.8M
- Latest round: Series B (Jul 18, 2025)
- Investors on record: 5

## About

Founded in 2022 and based in Kyoto, Japan, Link Therapeutics is a biotechnology company that develops treatments that target autoantibodies. Link Therapeutics operates as a biotechnology company that engages in the research and development of treatments that target autoantibodies. In July 2025, Link Therapeutics Inc. raised JPY 850 million in?series B funding ?from new investors ITOCHU Technology Ventures, SMBC Venture Capital and Kobe University Capital, with participation from other returning investors Kyoto University Innovation Capital and Mitsubishi UFJ Capital. The company plans to use its proceeds from July 2025 funding for research and development of its proprietary medical devices and pharmaceuticals, and to advance its fundamental technologies.

## Funding rounds

- Series B, Jul 18, 2025, $5.8M — Mitsubishi UFJ Capital, ITOCHU Technology Ventures, SMBC Venture Capital, Kyoto University Innovation Capital, Kobe University Capital
- Series A, Mar 4, 2023, $2.1M — Mitsubishi UFJ Capital

## Investors

- Mitsubishi UFJ Capital (https://capitalatlas.ai/funds/mitsubishi-ufj-capital) — Series A, Series B
- ITOCHU Technology Ventures (https://capitalatlas.ai/funds/itochu-technology-ventures) — Series B
- SMBC Venture Capital (https://capitalatlas.ai/funds/smbc-venture-capital) — Series B
- Kyoto University Innovation Capital (https://capitalatlas.ai/funds/kyoto-university-innovation-capital) — Series B
- Kobe University Capital (https://capitalatlas.ai/funds/kobe-university-capital) — Series B